RxDoctor Payments Data

Parimal Desai, MD

Family Medicine · Centreville, VANPI 1134113285

Payments from drug & device makers

$1,098in general payments, 2019–2025

Across 62 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$237
  • AbbVie$204
  • AstraZeneca$112
  • Pfizer$91
  • Amgen$72
  • Lilly USA, LLC$66
  • plus $317 from 11 others

What the payments were for

  • Food & beverage$1,098100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,098 in reported general payments places this provider in the 65th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$315,320
Medicare patients
380
Services billed
2,788

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban62$79,149
JardianceEmpagliflozin40$67,781
FarxigaDapagliflozin Propanediol43$44,572
OzempicSemaglutide30$41,701
JanuviaSitagliptin Phosphate24$37,619
TrulicityDulaglutide28$33,640
EntrestoSacubitril/Valsartan11$21,092
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$19,318
XareltoRivaroxaban15$14,035
LinzessLinaclotide14$12,840
Wixela InhubFluticasone Propion/Salmeterol43$5,964
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$4,924
Rosuvastatin Calcium227$3,111
Pantoprazole Sodium155$2,792
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$2,398

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$91$79,14962 claims
AstraZenecaFarxiga$112$44,57243 claims
Novo NordiskOzempic$237$41,70130 claims
MerckJanuvia$65$37,61924 claims
Lilly USA, LLCTrulicity$66$33,64028 claims
NovartisEntresto$15$21,09211 claims
GSKTrelegy Ellipta$47$19,31814 claims
Johnson & JohnsonXarelto$19$14,03515 claims
AbbVieLinzess$204$12,84014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Centreville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →